These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18610730)

  • 21. The Supreme Court, preemption, and malpractice liability.
    Kesselheim AS; Studdert DM
    N Engl J Med; 2009 Feb; 360(6):559-61. PubMed ID: 19196672
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA preemption of conflicting state drug regulation and the looming battle over abortion medications.
    Grossi P; O'Connor D
    J Law Biosci; 2023; 10(1):lsad005. PubMed ID: 36938304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation.
    Morten CJ; Kesselheim AS; Ross JS
    J Law Med Ethics; 2019 Dec; 47(4):783-787. PubMed ID: 31957583
    [No Abstract]   [Full Text] [Related]  

  • 24. The federal preemption debate in pharmaceutical labeling product liability actions.
    Gross JM; Curry JA
    Tort Trial Insur Pract Law J; 2007; 43(1):35-70. PubMed ID: 18354866
    [No Abstract]   [Full Text] [Related]  

  • 25. Implied preemption of state tort law claims against prescription drug manufacturers based upon FDA approval.
    Blair WW
    J Leg Med; 2006 Sep; 27(3):289-303. PubMed ID: 16959653
    [No Abstract]   [Full Text] [Related]  

  • 26. Preemption and malpractice liability.
    Hauser RG
    N Engl J Med; 2009 May; 360(21):2257-8; author reply 2258. PubMed ID: 19458378
    [No Abstract]   [Full Text] [Related]  

  • 27. Greater and lesser powers of tort reform: the primary jurisdiction doctrine and state-law claims concerning FDA-approved products.
    Struve CT
    Cornell Law Rev; 2008 Jul; 93(5):1039-74. PubMed ID: 18618970
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 29. Permitting product liability litigation for FDA-approved drugs and devices promotes patient safety.
    Kesselheim AS
    Clin Pharmacol Ther; 2010 Jun; 87(6):645-7. PubMed ID: 20485322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preemption and medical devices: a response to Adler and Mann.
    Hermann M; Ritts GJ
    Food Drug Law J; 1996; 51(1):1-19. PubMed ID: 11794345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription drugs, products liability, and preemption of tort litigation.
    DeAngelis CD; Fontanarosa PB
    JAMA; 2008 Oct; 300(16):1939-41. PubMed ID: 18940985
    [No Abstract]   [Full Text] [Related]  

  • 32. Tort claims and federal regulation of medical devices vs pharmaceuticals.
    Green M
    JAMA; 2009 Sep; 302(11):1169; author reply 1169-70. PubMed ID: 19755694
    [No Abstract]   [Full Text] [Related]  

  • 33. Repositioning Generics: The Comparative Value of Liability in FDA's Proposed Rule on Labeling.
    Falcone N
    Am J Law Med; 2015; 41(2-3):483-504. PubMed ID: 26591830
    [No Abstract]   [Full Text] [Related]  

  • 34. The FDA, contraceptive marketing approval and products liability litigation: Depo-Provera and the risk of osteoporosis.
    Green W
    Food Drug Law J; 2013; 68(2):115-35, i. PubMed ID: 24640465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug preemption and the need to reform the FDA consultation process.
    Gilhooley M
    Am J Law Med; 2008; 34(4):539-61. PubMed ID: 19216247
    [No Abstract]   [Full Text] [Related]  

  • 36. How Much Information is Enough? Understanding the Alabama Supreme Court's Expansion of the Causation Standard in Failure to Warn Claims.
    Herr A
    Am J Law Med; 2023 Mar; 49(1):128-133. PubMed ID: 37376912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical devices; preemption of state product liability claims--FDA. Withdrawal of proposed rule.
    Fed Regist; 1998 Jul; 63(142):39789-90. PubMed ID: 10181516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. States' Rights, Gun Violence Litigation, and Tort Immunity.
    Higgins HJ; Lowy JE; Rising AJ
    J Law Med Ethics; 2020 Dec; 48(4_suppl):83-89. PubMed ID: 33404317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highlights and a hidden hazard--the FDA's new labeling regulations.
    Avorn J; Shrank W
    N Engl J Med; 2006 Jun; 354(23):2409-11. PubMed ID: 16760439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.